Research study Program year 2023 Source: CMS Open Payments

Tv53408-Imm-1097

Research payments

$80,341

20 payments

Through program year 2023, $80,341 in research payments was reported against Tv53408-Imm-1097, across 20 payments, paid by Teva Pharmaceuticals USA, Inc..

Paid by: Teva Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$80,341	20

Breakdown

Who paid Research payments · program year 2023

Teva Pharmaceuticals USA, Inc. $80,341 20 payments

Who received the money Research payments · program year 2023

Gastroenterology Associates Of Western Michigan Plc Organisation paid for research $48,078 13 payments
Advanced Research INC Organisation paid for research $32,263 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.